Cytomegalovirus infection as a cause of pulmonary disease in HIV-infected patients
- James H Shelhamer, MD
James H Shelhamer, MD
- Deputy Chief, Critical Care Medicine Department, Clinical Center
- National Institutes of Health
Patients with HIV infection can present with fever, dyspnea, hypoxemia, and a chest radiograph showing diffuse pulmonary infiltrates (see "Approach to the HIV-infected patient with pulmonary symptoms"). Even in the era of highly active antiretroviral therapy, the most common etiologies of pneumonia in this setting are still Pneumocystis jirovecii; bacteria and a variety of other entities also enter the differential diagnosis, including cytomegalovirus pneumonia [1,2].
Although cytomegalovirus (CMV) may produce serious sequelae and death among organ transplant recipients (see "Prevention of cytomegalovirus infection in lung transplant recipients"), its significance as a pulmonary pathogen in HIV-infected patients is often unclear . The data regarding CMV as a pulmonary pathogen in patients with HIV infection and the prognosis and efficacy of treatment of CMV-related pulmonary disease in this setting will be reviewed here.
Autopsy studies are the most abundant source of evidence for CMV as a cause of pulmonary disease in HIV-infected patients. In a study of 75 autopsies of patients with HIV infection, 38 of whom were thought to have died of respiratory failure, 44 patients (59 percent) had histologic evidence of CMV infection . In over one-half of these patients, the CMV was thought to cause little or no pulmonary dysfunction. In contrast, CMV was thought to play some role in 21 of the 44 patients (as a sole pathogen in 6 patients and as a contributory pathogen in 15).
In another study of 54 patients who died with HIV infection, 31 patients (57 percent) had histologic evidence of CMV infection in the lung found at autopsy . One half of the patients with evidence for CMV pneumonitis were thought to have died of respiratory failure, although other causative agents were also found in most of these patients.
Therefore, histologic evidence of CMV pneumonitis is frequently present at autopsy in HIV-infected patients, but CMV is not commonly found as the sole pathogen.
Subscribers log in hereLiterature review current through: Jul 2017. | This topic last updated: Jun 15, 2017.References
- Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30 Suppl 1:S5.
- Rimland D, Navin TR, Lennox JL, et al. Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infection. AIDS 2002; 16:85.
- Baughman RP. Cytomegalovirus: the monster in the closet? Am J Respir Crit Care Med 1997; 156:1.
- McKenzie R, Travis WD, Dolan SA, et al. The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary diseases. Medicine (Baltimore) 1991; 70:326.
- Wallace JM, Hannah J. Cytomegalovirus pneumonitis in patients with AIDS. Findings in an autopsy series. Chest 1987; 92:198.
- Salomon N, Gomez T, Perlman DC, et al. Clinical features and outcomes of HIV-related cytomegalovirus pneumonia. AIDS 1997; 11:319.
- Uberti-Foppa C, Lillo F, Terreni MR, et al. Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease. Chest 1998; 113:919.
- Millar AB, Patou G, Miller RF, et al. Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger? Am Rev Respir Dis 1990; 141:1474.
- Miles PR, Baughman RP, Linnemann CC Jr. Cytomegalovirus in the bronchoalveolar lavage fluid of patients with AIDS. Chest 1990; 97:1072.
- Mann M, Shelhamer JH, Masur H, et al. Lack of clinical utility of bronchoalveolar lavage cultures for cytomegalovirus in HIV infection. Am J Respir Crit Care Med 1997; 155:1723.
- Joos L, Chhajed PN, Wallner J, et al. Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients. Respir Med 2007; 101:93.
- Clarke JR, Fleming J, Donegan K, et al. Effect of HIV-1 and cytomegalovirus in bronchoalveolar lavage cells on the transfer factor for lung carbon monoxide in AIDS patients. AIDS 1991; 5:1333.
- Jacobson MA, Mills J, Rush J, et al. Morbidity and mortality of patients with AIDS and first-episode Pneumocystis carinii pneumonia unaffected by concomitant pulmonary cytomegalovirus infection. Am Rev Respir Dis 1991; 144:6.
- Bozzette SA, Arcia J, Bartok AE, et al. Impact of Pneumocystis carinii and cytomegalovirus on the course and outcome of atypical pneumonia in advanced human immunodeficiency virus disease. J Infect Dis 1992; 165:93.
- Hayner CE, Baughman RP, Linnemann CC Jr, Dohn MN. The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV. Chest 1995; 107:735.
- Bower M, Barton SE, Nelson MR, et al. The significance of the detection of cytomegalovirus in the bronchoalveolar lavage fluid in AIDS patients with pneumonia. AIDS 1990; 4:317.
- Waxman AB, Goldie SJ, Brett-Smith H, Matthay RA. Cytomegalovirus as a primary pulmonary pathogen in AIDS. Chest 1997; 111:128.
- Jensen AM, Lundgren JD, Benfield T, et al. Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? A note for caution. Chest 1995; 108:411.
- Hyland M, Chan M, Hyland RH, Chan CK. Associating poor outcome with the presence of cytomegalovirus in bronchoalveolar lavage from HIV patients with Pneumocystis carinii pneumonia. Chest 1995; 107:595.
- Rodriguez-Barradas MC, Stool E, Musher DM, et al. Diagnosing and treating cytomegalovirus pneumonia in patients with AIDS. Clin Infect Dis 1996; 23:76.
- Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med 1988; 108:585.
- Youle M, Chanas A, Gazzard B. Treatment of acquired immune deficiency syndrome (AIDS)-related pneumonitis with foscarnet: a double-blind placebo controlled study. J Infect 1990; 20:41.
- Wallace JM, Rao AV, Glassroth J, et al. Respiratory illness in persons with human immunodeficiency virus infection. The Pulmonary Complications of HIV Infection Study Group. Am Rev Respir Dis 1993; 148:1523.